- Poster presentation
- Open Access
Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
© Matsuzaki et al; licensee BioMed Central Ltd. 2014
- Published: 7 January 2014
- Family History
- Blood Transfusion
- Early Diagnosis
- Lower Extremity
Early diagnosis and medical intervention are important for functional prognosis of HAM/TSP patients. In order to find out patients with early stage of HAM/TSP, we started HTLV-1 carrier clinic in the endemic area, Kagoshima, Japan, in 1999. Till the end of 2012, 407 persons have visited the clinic as first time-visitors of HTLV-1 carriers, and 6 cases were diagnosed as early stage of HAM/TSP. These 6 cases are 1 male and 5 females, 20-55 years old (mean=41.8) at the diagnosis, no history of blood transfusion, and 4 cases have family history of HAM/TSP. They could run and had no subjective symptoms on motor function, but all had subjective symptoms either dysesthesia/pain or urinary disturbances. Physical examination demonstrated hyper-reflexes of lower extremities with mild spasticity, positive Babinski signs, and decreased sweating of lower trunk and legs. Laboratory test showed positive anti-HTLV-1 antibodies in both sera and CSF, and proviral loads in the blood were high (386-2181 copies/104 PBMC) in all cases. Two cases were treated with steroids and their urinary disturbances were improved. After 2 years of follow up, their symptoms remained unchanged and decrease of proviral load was obtained in one case. These experiences in HTLV-1 carrier clinic indicate that early diagnosis of HAM/TSP is possible by careful medical checking of HTLV-1-positive individuals. Decrease of sweating in lower body, and hyper-reflexes of legs with typical Babinski sign are important signs for early diagnosis. Treatment intervention at early stage of the disease might improve functional prognosis of HAM/TSP patients.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.